Award
Delivery Order #SPE2DR26FL358
Delivery Order for Pharmaceutical Supplies to Support Healthcare Agencies
Buyer
Defense Logistics Agency
Award Amount
$8.14
Ceiling
$8.14
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2DR26FL358
NAICS
424210
This award represents a delivery order under an existing indefinite delivery/indefinite quantity (IDIQ) contract granted to AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company known for its comprehensive healthcare solutions. The delivery order procures a specific pharmaceutical product, Amoxicillin-Clavulanate suspension, reinforcing the long-term collaboration initiated by the parent contract focused on pharmaceutical product supply. This contract is critical for ensuring uninterrupted access to key medications that aid healthcare providers in delivering quality patient care. Scope of work includes timely delivery of specified pharmaceutical products to designated locations, supporting efficient healthcare supply chains. The award was made under a competitive framework established by the parent IDIQ contract, ensuring fair procurement practices. The performance period for this delivery order is short-term, covering a two-day window, highlighting the contract's role in meeting immediate pharmaceutical needs.
Description
4570969492!AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML